Allele loss in wilms tumors of chromosome arms 11q, 16q, and 22q correlates with clinicopathological parameters

Genes Chromosomes and Cancer

Volumn 22, Issue 4, 1998, Pages 287-294

  Klamt, Barbara ^a   Schulze, Michael ^a   Thäte, Claudia ^a   Mares, Jaroslav ^b   Goetz, Peter ^b   Kodet, Roman ^b   Scheurlen, Wolfram ^c   Welrich, Angela ^d   Graf, Norbert ^d   Gessler, Manfred ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC CARCINOMA; ARTICLE; CANCER RECURRENCE; CHROMOSOME 11Q; CHROMOSOME 16Q; CHROMOSOME 22Q; CHROMOSOME LOSS; CONTROLLED STUDY; DISEASE COURSE; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEPHROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031747351     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199808)22:4<287::AID-GCC4>3.0.CO;2-R     Document Type: Article

References (40)

1. Altura RA, Valentine M, Li H, Boyett JM, Shearer P, Grundy P, Shapiro DN, Look AT (1996) Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization. Cancer Res 56:3837-3841.
2. Austruy E, Candon S, Henry I, Gyapay G, Tournade MF, Mannens M, Gallen D, Junien C, Jeanpierre C (1995) Characterization of regions of chromosomes 12 and 16 involved in nephroblastoma tumorigenesis. Genes Chromosomes Cancer 14:285-294.
3. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (1994) Current Protocols in Molecular Biology. New York: John Wiley & Sons, Inc.
4. Bardeesy N, Falkoff D, Petruzzi MJ, Nowak N, Zabel B, Adam M, Aguiar MC, Grundy P, Shows T, Pelletier J (1994) Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbors p53 gene mutations. Nat Genet 7:91-97.
5. Becker KK, Reich U, Schott C, Hofler H (1995) Single nucleotide polymorphisms in the human E-cadherin gene. Hum Genet 96:739-740.
6. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Krai A, Yeger H, Lewis WH, Jones C, Housman DE (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509-520.
7. Coppes MJ, Bonetta L, Huang A, Huban P, Chiltonmacneill S, Campbell CE, Weksberg R, Yeger H, Reeve AE, Williams BRG (1992) Loss of heterozygosity mapping in Wilms' tumor indicates the involvement of 3 distinct regions and a limited role for nondisjunction or mitotic recombination. Genes Chromosomes Cancer 5:326-334.
8. Delemarre JF, Sandstedt B, Harms D, Boccon-Gibod L, Vujanic GM (1996) The new SIOP (Stockholm) working classification of renal tumours of childhood. International Society of Paediatric Oncology (letter). Med Pediatr Oncol 26:145-146.
9. Doggett NA, Goodwin LA, Tesmer JG, Meincke LJ, Brnce DC, Clark LM, Altherr MR, Ford AA, Chi HC, Marrone BL, Longmire JL, Lane SA, Whitmore SA, Lowenstein MG, Sutherland RD, Mundt MO, Knill EH, Bruno WJ, Macken CA, Torney DC, Wu JR, Griffith J, Sutherland GR, Deaven LL, Callen DF (1995) An integrated physical map of human chromosome 16. Nature 377:335-365.
10. Garvin AJ, Re GG, Tarnowski BI, Hazenmartin DJ, Sens DA (1993) The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney. Am J Pathol 142:375-380.
11. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA (1990) Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature. 343:774-778.
12. Gessler M, König A, Arden K, Grundy P, Orkin S, Sallan S, Peters C, Ruyle S, Mandell J, Li F, Cavenee W, Bruns G (1994) Infrequent mutation of the WT1 gene in 77 Wilms' tumors. Hum Mut 3:212-222.
13. Grundy P, Koufos A, Morgan K, Li KP, Meadows AT, Cavenee WK (1988) Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11. Nature 366:374-376.
14. Grundy PE, Telzerow PE, Breslow N, Moksness J, Huff V, Paterson MC (1994) Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome. Cancer Res 54:2331-2333.
15. Grundy P, Telzerow P, Moksness J, Breslow NE (1996) Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: A preliminary analysis. Med Pediatr Oncol 27:429-433.
16. Hoggard N, Hey Y, Brintnell B, James L, Jones D, Mitchell E, Weissenbach J, Varley JM (1995) Identification and cloning in yeast artificial chromosomes of a region of elevated loss of heterozygosity on chromosome 1p31.1 in human breast cancer. Genomics 30:233-243.
17. Hoovers JMN, Kalikin LM, Johnson LA, Alders M, Redeker B, Law DJ, Bliek J, Steenman M, Benedict M, Wiegant J, Lengauer C, Taillonmiller P, Schlessinger D, Edwards MC, Elledge SJ, Ivens A, Westerveld A, Little P, Mannens M, Feinberg AP (1995) Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragments. Proc Natl Acad Sci USA 92:12456-12460.
18. Huff V, Saundcrs GF (1993) Wilms' tumor genes. Biochimica Biophysica Acta 1155:295-306.
19. Huff V, Reeve AE, Leppert M, Strong LC, Douglass EC, Geiser CF, Li KP, Meadows A, Callen DF, Lenoir G, Saunders GF (1992) Nonlinkage of 16q markers to familial predisposition to Wilms' tumor. Cancer Res 52:6117-6120.
20. Huff V, Amos CI, Douglass EC, Fisher R, Geiser CF, Krill CE, Li FP, Strong LC, McDonald JM (1997) Evidence for genetic heterogeneity in familial VVilms' tumor. Cancer Res 57:1859-1862.
21. Koufos A, Grundy P, Morgan K, Aleck KA, Hadro T, Lampkin BC, Kalbakji A, Cavenee WK (1989) Familial Wiedemann-Beckwith syndrome and a second Wilms' tumor locus both map to 11p15.5. Am J Hum Genet 44:711-719.
22. Lahoti C, Thorner P, Malkin ID, Yeger H (1996) Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome. Am J Pathol 148:1577-1589.
23. Law MH, Algar E, Little M (1997) Allelic imbalance at chromosome 1q21 in Wilms' tumor. Cancer Genet Cytogenet 97:54-59.
24. Lee MP, DeBaun M, Randhawa G, Reichard BA, Elledge SJ, Feinberg AP (1997) Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome. Am J Hum Genet 61:304-309.
25. Little M, Wells C (1997) A clinical overview of WT1 gene mutations. Hum Mutat 9:209-225.
26. Mannens M, Slater RM, Heyting C, Blick J, de Kraker J, Coud N, de Paper-Holthuizen P, Pearson PL (1988) Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumors. Hum Genet 81:41-48.
27. Maw MA, Grundy PK, Millow LJ, Eccles MR, Dunn RS, Smith PJ, Feinberg AP, Law DJ, Paterson MC, Telzerow PE, Callen DF, Thompson AD, Richards RI, Reeve AE (1992) A third Wilms' tumor locus on chromosome 16q. Cancer Res 52:3094-3098.
28. Miozzo M, Perotti D, Minoletti F, Mondini P, Pilotti S, Luksch R, Fossati-Bellani F, Picrotti MA, Sozzi G, Radice P (1996) Mapping of a putative tumor suppressor locus to proximal 7p in Wilms' tumors. Genomics 37:310-315.
29. O'Keefe 13, Dao D, Zhao L, Sanderson R, Warburton D, Weiss L, Anyane-Yeboa K, Tycko B (1997) Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms' tumors. Am J Hum Genet 61:295-303.
30. Radice P, Perotti D, Debenedetti V, Mondini P, Radice MT, Pilotti S, Luksch R, Bellani FE, Pierotti MA (1995) Allelotyping in Wilms' tumors identifies a putative third tumor suppressor gene on chromosome 11. Genomics 27:497-501.
31. Rahman N, Arbour L, Tonin P, Renshaw J, Pelletier J, Baruchel S, Pritchard-Jones K, Stratton MR, Narod SA (1996) Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21. Nat Genet 13:461-463.
32. Reeve AE, Sih SA, Raizis AM, Feinberg AP (1989) Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells. Mol Cell Biol 9:1799-1803.
33. Reid LH, Davies C, Cooper PR, Crider-Miller SJ, Sait SN, Nowak NJ, Evans G, Stanbridge EJ, deJong P, Shows TB, Weissman BE, Higgins MJ (1997) A 1-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPA1 and the BWSCR1/wt2 region. Genomics 43:366-375.
34. Schofield DE, Beckwith JB, Sklar J (1996) Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors. Genes Chromosomes Cancer 15:10-17.
35. Schumacher V, Schneider S, Figge A, Wildhardt G, Harms D, Schmidt D, Weirich A, Ludwig R, Royer-Pokora B (1997) Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms' tumors of stromal-predominant histology. Proc Natl Acad Sci USA 94:3972-3977.
36. Steenman M, Redeker B, de Meulemeester M, Wiesmeijer K, Voute PA, Westerveld A, Slater R, Mannens M (1997) (Comparative genomic hybridization analysis of Wilms' tumors. Cytogenet Cell Genet 77:296-303.
37. Taniguchi T, Sullivan MJ, Ogawa O, Reeve AE (1995) Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms' tumor. Proc Natl Acad Sci USA 92:2159-2163.
38. Varanasi R, Bardeesy N, Ghahremani M, Petruzzi MJ, Nowak N, Adam MA, Grundy P, Shows TB, Pelletier J (1994) Fine structure analysis of the WT1 gene in sporadic Wilms' tumors. Proc Natl Acad Sci USA 91:3554-3558.
39. Weith A, Brodeur GM, Bruns GA, Matise TC, Mischke D, Nizetic D, Seidin MF, van Roy N, Vance J (1996) Report of the second international workshop on human chromosome 1 mapping 1995. Cytogenet Cell Genet 72:114-144.
40. Winqvist R, Hampton GM, Mannermaa A, Blanco G, Alavaikko M, Kiviniemi H, Taskinen PJ, Kvans GA, Wright FA, Newsham I, Cavenee WK (1995) Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res 55:2660-2664.